Shared Research logo
  • Home
  • All Companies
    All Companies
    Companies
    Recently viewed
    Browse companies...
  • English日本語
  • Log in
  • Sign up
Overview
My Comments
My Notes
Solasia Pharma

Solasia Pharma 4597

ソレイジア・ファーマ
Recent Updates
2022-07-01
Conclusion of a sublicensing agreement for the sales rights of Sancuso and episil, announcement of dissolving of Chinese subsidiary's sales network 
2022-06-29
Capital and business alliance with Nippon Kayaku and issuance of new shares via third-party allotment
2022-06-21
Obtained marketing approval for Darvias Injection 135mg 
Get in touch
4F, Sumitomo Fudosan Shiba-koen Tower, 2-11-1, Shiba-koen, Minato-ku, Tokyo 105-0011, Japan
https://www.solasia.co.jp/
Summary
Solasia Pharma is a biotech venture that in-licenses development and sales rights for new drugs developed in the US and Europe to commercialize them in Japan and other parts of Asia.
Biotechnology
Key dates
2017-10-31
Coverage initiation